We've blogged a lot about POM lately. We have yet one more quick update on our recent blog post about POM's suit against the FTC. The FTC struck back this week, filing suit against POM, its sister corporation Roll International Corp., and principals Stewart Resnick, Lynda Resnick and Matthew Tupper, alleging that the Company's advertising overstated the health benefits of its products.
The Complaint against POM alleges that the Company's advertising contains "false or unsubstantiated claims" about preventing or treating a number of diseases, including prostate cancer, heart disease, and erectile dysfunction. The FTC's proposed relief, among other things, would require POM to have FDA approval for any future claims it wishes to assert relating to the preventative or curative nature of its products. Because the FTC filed an administrative complaint the requested relief does not include consumer redress but the agency reserves the right to petition a federal court for such relief.